专利信息

首页 1 2 3 4 5 6 下页尾页共 536 条记录, 当前第1/54页。

专利标题：A kind of method of utilizing daunorubicin fermentation liquor to produce daunorubicin hydrochloride

专利标题：Injection daunorubicin composite freeze-dried powder

New uses for phenylketone carboxylate compounds and substituted aromatic compounds of Formula I Formula I.1 Formula I.2 Formula IA Formula IB Formula IC and Formula II and their pharmaceutical acceptable salts for the treatment of cancer. The use of a combination of two of these compounds is described and the use of the combination of one of these compounds with an anticancer agent such as decarbazine doxorubicin daunorubicin cyclophosphamide busulfex busulfan vinblastine vincristine bleomycin e...

专利标题：Compounds and compositions for the treatment of cancer

专利权人：Prometic Biosciences, Inc.;

专利标题：Compound and composition for treatment of cancer

专利权人：Prometic Biosciences Inc.;

专利标题：EPIMERIZATION OF 4'-C BOND AND MODIFICATION OF 14-CH3-(CO)-FRAGMENT IN ANTHRACYCLIN ANTIBIOTICS

专利权人：SOLUX CORP [US];

A method of synthesizing R1, R2-substituted-4' (ax. or eq.)-OH anthracyclines and their corresponding salts of Formula (1) from daunorubicin or N-Trifluoroacetyl-4- RI - derivatives of daunorubicin, wherein R1 is defined as H, OH, and 4'-HO is defined as ax[ial]. The method includes producing N-Trifluoroacetyl daunorubicin and treating the N- Trifluoroacetyldaunorubicin or N-Trifluoroacetyl-4-R1 -derivatives of daunorubicin, wherein R1 is defined as H, OH, with dimethylsulfoxide activated by dif...

专利标题：Compounds and compositions for the treatment of cancer

专利权人：Prometic Biosciences Inc.;

专利标题：The compositions of l-epicatechin gallate and daunorubicin and application thereof

专利权人：Fudan University;

专利标题：Compounds and compositions for the treatment of cancer.

专利权人：Prometic Biosciences Inc.;

专利标题：Compounds and compositions for the treatment of cancer

专利权人：Prometic Biosciences Inc.;

当前查询条件: [药品] 包含 'Daunorubicin '

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. CN103641868A	2014/3/19
专利标题：A kind of method of utilizing daunorubicin fermentation liquor to produce daunorubicin hydrochloride 专利权人：

2. CN103536545A	2014/1/29
专利标题：Injection daunorubicin composite freeze-dried powder 专利权人：

3. JP2013544799A	2013/12/19	JP20130535215	2011/10/26
专利标题：专利权人： New uses for phenylketone carboxylate compounds and substituted aromatic compounds of Formula I Formula I.1 Formula I.2 Formula IA Formula IB Formula IC and Formula II and their pharmaceutical acceptable salts for the treatment of cancer. The use of a combination of two of these compounds is described and the use of the combination of one of these compounds with an anticancer agent such as decarbazine doxorubicin daunorubicin cyclophosphamide busulfex busulfan vinblastine vincristine bleomycin e...

4. KR20130132448A	2013/12/4	KR20137013238	2011/10/26
专利标题：Compounds and compositions for the treatment of cancer 专利权人：Prometic Biosciences, Inc.; New uses for phenylketone carboxylate compounds and substituted aromatic compounds of Formula I Formula I.1 Formula I.2 Formula IA Formula IB Formula IC and Formula II and their pharmaceutical acceptable salts for the treatment of cancer. The use of a combination of two of these compounds is described and the use of the combination of one of these compounds with an anticancer agent such as decarbazine doxorubicin daunorubicin cyclophosphamide busulfex busulfan vinblastine vincristine bleomycin e...

5. CN103347509A	2013/10/9	CN2011852340	2011/10/26
专利标题：Compound and composition for treatment of cancer 专利权人：Prometic Biosciences Inc.;

6. EP2636411A1	2013/9/11	EP20130170431	2006/3/6
专利标题：EPIMERIZATION OF 4'-C BOND AND MODIFICATION OF 14-CH3-(CO)-FRAGMENT IN ANTHRACYCLIN ANTIBIOTICS 专利权人：SOLUX CORP [US]; A method of synthesizing R1, R2-substituted-4' (ax. or eq.)-OH anthracyclines and their corresponding salts of Formula (1) from daunorubicin or N-Trifluoroacetyl-4- RI - derivatives of daunorubicin, wherein R1 is defined as H, OH, and 4'-HO is defined as ax[ial]. The method includes producing N-Trifluoroacetyl daunorubicin and treating the N- Trifluoroacetyldaunorubicin or N-Trifluoroacetyl-4-R1 -derivatives of daunorubicin, wherein R1 is defined as H, OH, with dimethylsulfoxide activated by dif...

7. US20130217645A1	2013/8/22	US13/882355	2011/10/26
专利标题：Compounds and compositions for the treatment of cancer 专利权人：Prometic Biosciences Inc.; New uses for phenylketone carboxylate compounds and substituted aromatic compounds of Formula I Formula I.1 Formula I.2 Formula IA Formula IB Formula IC and Formula II and their pharmaceutical acceptable salts for the treatment of cancer. The use of a combination of two of these compounds is described and the use of the combination of one of these compounds with an anticancer agent such as decarbazine doxorubicin daunorubicin cyclophosphamide busulfex busulfan vinblastine vincristine bleomycin e...

8. CN102232960B	2013/8/21
专利标题：The compositions of l-epicatechin gallate and daunorubicin and application thereof 专利权人：Fudan University;

9. MX2013004832A	2013/5/22	MX20130004832	2013/4/26
专利标题：Compounds and compositions for the treatment of cancer. 专利权人：Prometic Biosciences Inc.; New uses for phenylketone carboxylate compounds and substituted aromatic compounds of Formula I Formula I.1 Formula I.2 Formula IA Formula IB Formula IC and Formula II and their pharmaceutical acceptable salts for the treatment of cancer. The use of a combination of two of these compounds is described and the use of the combination of one of these compounds with an anticancer agent such as decarbazine doxorubicin daunorubicin cyclophosphamide busulfex busulfan vinblastine vincristine bleomycin e...

10. AU2011356583A1	2013/5/9	AU20110356583	2011/10/26
专利标题：Compounds and compositions for the treatment of cancer 专利权人：Prometic Biosciences Inc.; New uses for phenylketone carboxylate compounds and substituted aromatic compounds of Formula I Formula I.1 Formula I.2 Formula IA Formula IB Formula IC and Formula II and their pharmaceutical acceptable salts for the treatment of cancer. The use of a combination of two of these compounds is described and the use of the combination of one of these compounds with an anticancer agent such as decarbazine doxorubicin daunorubicin cyclophosphamide busulfex busulfan vinblastine vincristine bleomycin e...

下载范围

下载内容